The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18505180

Download in:

View as

General Info

PMID
18505180